Clinical Study

Stroke Prevention Trial Comparing Rivaroxaban To Aspirin At Preventing Another Stroke In Patients Who Recently Had A Stroke Of Undetermined Cause.

Posted Date: Feb 22, 2017

  • Investigator: Dawn Kleindorfer
  • Co-Investigator: Cynthia Callihan
  • Specialties: Neurosurgery, Stroke, Neurology
  • Type of Study: Drug

The purpose of this study is to compare two drugs in preventing blood clots, rivaroxaban and aspirin. The study drug rivaroxaban/Xarelto® has not yet been approved by the Federal Drug Administration (FDA) for secondary prevention of blood clots in th


We Are Asking You To Take Part In This Research Study Because You Are 18 Years Of Age Or Older And You Have Recently Had A Brain Attack (Also Called A Stroke) Due To A Lack Of Blood Flow To Part Of Your Brain That May Have Been Caused By A Blood Clot. In


Cerebrovascular Accident, Rivaroxaban, Stroke, Blood Clot, Aspirin

For More Information:

Alisha Hodge, Rn, Bsn
(513) 558-5149

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.